A pilot cohort study on infants with new-onset epilepsy examines the clinical utility of rapid genome sequencing

The clinical impact of rapid genome sequencing of infants with new-onset epilepsy.

Zuckerberg and Chan on track to put $50 billion toward science: ‘That’s the trajectory we’re on’

Mark Zuckerberg and Priscilla Chan sit atop a fortune that is currently valued at $113 billion, and they’ve promised to give almost all of it

October 19, 2023

Bain, Atlas, RTW back new biotech developing obesity drugs with $400M

A new obesity biotech has entered the field — and it has $400 million from well-known life sciences investors to test investigational GLP-1 and GIP

May 17, 2024

Fianlimab by Regeneron Pharmaceuticals for Lymphoma: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

June 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.